Pomalidomide is a familiar myeloma therapy, but perhaps one that isn't as frequently used. Learn its mechanism of action, efficacy and side effects from Dr. Suvannasankha and come with your questions.
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Dr. Suvannasankha is a graduate of Chulalongkorn University in Thailand. She completed her residency at Albert Einstein Medical Center in Philadelphia and a fellowship at Roswell Park Comprehensive Cancer Center in Buffalo, New York. She joined the Indiana University School of Medicine in 2003 and currently serves as an associate professor at the IU School of Medicine and researcher at the IU Simon Comprehensive Cancer Center. Dr. Suvannasankha’s research interests are in the molecular mechanism of drug resistance in hematologic malignancy and precision medicine. Her clinical expertise includes hematology-oncology and bone marrow transplant.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.